Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland.

Rinta-Kokko H, Auranen K, Toropainen M, Nuorti JP, Nohynek H, Siira L, Palmu AA.

Vaccine. 2019 Nov 29. pii: S0264-410X(19)31591-9. doi: 10.1016/j.vaccine.2019.11.049. [Epub ahead of print]

PMID:
31791813
2.

Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.

Edwards K, Hanquet G, Black S, Mignot E, Jankosky C, Shimabukuro T, Miller E, Nohynek H, Neels P.

Biologicals. 2019 Jul;60:1-7. doi: 10.1016/j.biologicals.2019.05.005. Epub 2019 May 23.

3.

Global vaccinology training: Report from an ADVAC workshop.

Duclos P, Martinez L, MacDonald N, Asturias E, Nohynek H, Lambert PH; all participants of the Global Vaccinology Training Workshop.

Vaccine. 2019 May 16;37(22):2871-2881. doi: 10.1016/j.vaccine.2019.02.062. Epub 2019 Mar 18.

4.

Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.

Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, Comanducci M, Lemos AP, Gorla MC, Křížová P, Mikula C, Mulhall R, Nissen M, Nohynek H, Simões MJ, Skoczyńska A, Stefanelli P, Taha MK, Toropainen M, Tzanakaki G, Vadivelu-Pechai K, Watson P, Vazquez JA, Rajam G, Rappuoli R, Borrow R, Medini D.

Vaccine. 2019 Feb 8;37(7):991-1000. doi: 10.1016/j.vaccine.2018.12.061. Epub 2019 Jan 17.

5.

Cohort study design for estimating the effectiveness of seasonal influenza vaccines in real time based on register data: The Finnish example.

Baum U, Auranen K, Kulathinal S, Syrjänen R, Nohynek H, Jokinen J.

Scand J Public Health. 2018 Nov 2:1403494818808635. doi: 10.1177/1403494818808635. [Epub ahead of print]

PMID:
30387371
6.

The prevalence of otitis media in 2-3 year old Cameroonian children estimated by tympanometry.

Libwea JN, Kobela M, Ndombo PK, Syrjänen RK, Huhtala H, Fointama N, Koulla-Shiro S, Nohynek H, Nuorti JP, Palmu AA.

Int J Pediatr Otorhinolaryngol. 2018 Dec;115:181-187. doi: 10.1016/j.ijporl.2018.10.007. Epub 2018 Oct 6.

7.

The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.

Skufca J, Ollgren J, Artama M, Ruokokoski E, Nohynek H, Palmu AA.

Vaccine. 2018 Sep 18;36(39):5926-5933. doi: 10.1016/j.vaccine.2018.06.074. Epub 2018 Aug 13.

8.

Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children.

Artama M, Rinta-Kokko H, Nohynek H, Jokinen J, Palmu AA.

Curr Drug Saf. 2018;13(2):107-112. doi: 10.2174/1574886313666180406164151.

9.

A pneumococcal conjugate vaccination programme reduced clinically suspected invasive disease in unvaccinated children.

Palmu AA, Rinta-Kokko H, Nuorti JP, Nohynek H, Jokinen J.

Acta Paediatr. 2018 Mar 25. doi: 10.1111/apa.14335. [Epub ahead of print]

PMID:
29577411
10.

Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.

Rinta-Kokko H, Palmu AA, Auranen K, Nuorti JP, Toropainen M, Siira L, Virtanen MJ, Nohynek H, Jokinen J.

Vaccine. 2018 Apr 5;36(15):1934-1940. doi: 10.1016/j.vaccine.2018.03.001. Epub 2018 Mar 8.

PMID:
29526371
11.

Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Jokinen J.

Pediatr Infect Dis J. 2018 Jan;37(1):97-102. doi: 10.1097/INF.0000000000001810.

PMID:
29088026
12.

Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere.

Pebody R, McMenamin J, Nohynek H.

Arch Dis Child. 2018 Jan;103(1):101-105. doi: 10.1136/archdischild-2016-312165. Epub 2017 Aug 30. Review.

PMID:
28855230
13.

Factors associated with routine childhood vaccine uptake and reasons for non-vaccination in India: 1998-2008.

Francis MR, Nohynek H, Larson H, Balraj V, Mohan VR, Kang G, Nuorti JP.

Vaccine. 2018 Oct 22;36(44):6559-6566. doi: 10.1016/j.vaccine.2017.08.026. Epub 2017 Aug 24.

14.

Decreased incidence of pertussis in young adults after the introduction of booster vaccine in military conscripts: Epidemiological analyses of pertussis in Finland, 1995-2015.

Zöldi V, Sane J, Nohynek H, Virkki M, Hannila-Handelberg T, Mertsola J.

Vaccine. 2017 Sep 18;35(39):5249-5255. doi: 10.1016/j.vaccine.2017.08.008. Epub 2017 Aug 18.

PMID:
28823620
16.

Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013.

Wu W, Liu D, Li K, Nuorti JP, Nohynek HM, Xu D, Ye J, Zheng J, Wang H.

Vaccine. 2017 Jun 22;35(29):3666-3671. doi: 10.1016/j.vaccine.2017.05.021. Epub 2017 May 25.

PMID:
28552510
17.

Establishing and maintaining the National Vaccination Register in Finland.

Baum U, Sundman J, Jääskeläinen S, Nohynek H, Puumalainen T, Jokinen J.

Euro Surveill. 2017 Apr 27;22(17). pii: 30520. doi: 10.2807/1560-7917.ES.2017.22.17.30520.

18.

Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017.

Hergens MP, Baum U, Brytting M, Ikonen N, Haveri A, Wiman Å, Nohynek H, Örtqvist Å.

Euro Surveill. 2017 Feb 23;22(8). pii: 30469. doi: 10.2807/1560-7917.ES.2017.22.8.30469. Erratum in: Euro Surveill. 2017 Mar 2;22(9):null.

19.

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J.

PLoS One. 2017 Mar 1;12(3):e0172690. doi: 10.1371/journal.pone.0172690. eCollection 2017.

20.

Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16.

Nohynek H, Baum U, Syrjänen R, Ikonen N, Sundman J, Jokinen J.

Euro Surveill. 2016 Sep 22;21(38). doi: 10.2807/1560-7917.ES.2016.21.38.30346.

21.

Distance to health services modifies the effect of an 11-valent pneumococcal vaccine on pneumonia risk among children less than 2 years of age in Bohol, Philippines.

Root ED, Lucero M, Nohynek H, Stubbs R, Tallo V, Lupisan SP, Sanvictores DM, Nillos LT, Simões EA; ARIVAC Team.

Int J Epidemiol. 2017 Apr 1;46(2):706-716. doi: 10.1093/ije/dyw217.

PMID:
27605588
22.

WU and KI polyomavirus infections in Filipino children with lower respiratory tract disease.

Rao S, Lucero MG, Nohynek H, Tallo V, Lupisan SP, Garcea RL, Simões EAF; ARIVAC Consortium.

J Clin Virol. 2016 Sep;82:112-118. doi: 10.1016/j.jcv.2016.07.013. Epub 2016 Jul 26.

PMID:
27479174
23.

Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?

Johansen K, Brasseur D, MacDonald N, Nohynek H, Vandeputte J, Wood D, Neels P; Scientific Committee.

Biologicals. 2016 Jul;44(4):276-280. doi: 10.1016/j.biologicals.2016.04.007. Epub 2016 Jun 18.

PMID:
27329008
24.

Comparison of microarray-predicted closest genomes to sequencing for poliovirus vaccine strain similarity and influenza A phylogeny.

Maurer-Stroh S, Lee CW, Patel C, Lucero M, Nohynek H, Sung WK, Murad C, Ma J, Hibberd ML, Wong CW, Simões EA.

Diagn Microbiol Infect Dis. 2016 Mar;84(3):203-6. doi: 10.1016/j.diagmicrobio.2015.11.003. Epub 2015 Nov 6.

25.

Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.

Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan V, Julkunen I, Vuorela A, Vaarala O, Nohynek H, Pasini FL, Montomoli E, Trombetta C, Adams CM, Rothbard J, Steinman L.

Sci Transl Med. 2015 Jul 1;7(294):294ra105. doi: 10.1126/scitranslmed.aab2354.

PMID:
26136476
26.

Disease mapping for informing targeted health interventions: childhood pneumonia in Bohol, Philippines.

Thomas DS, Anthamatten P, Root ED, Lucero M, Nohynek H, Tallo V, Williams GM, Simões EA; ARIVAC Consortium.

Trop Med Int Health. 2015 Nov;20(11):1525-1533. doi: 10.1111/tmi.12561. Epub 2015 Jul 21.

27.

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.

Palmu AA, Kilpi TM, Rinta-Kokko H, Nohynek H, Toropainen M, Nuorti JP, Jokinen J.

Pediatrics. 2015 Jul;136(1):e22-7. doi: 10.1542/peds.2015-0458. Epub 2015 Jun 15.

28.

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.

Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen MJ, Nohynek H, Virolainen-Julkunen A, Toropainen M, Nuorti JP.

PLoS One. 2015 Mar 17;10(3):e0120290. doi: 10.1371/journal.pone.0120290. eCollection 2015.

29.

Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine.

Haveri A, Ikonen N, Julkunen I, Kantele A, Anttila V, Ruotsalainen E, Nohynek H, Lyytikainen O, Savolainen-Kopra C.

Euro Surveill. 2015 Feb 5;20(5):21028. No abstract available.

30.

Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.

Vaarala O, Vuorela A, Partinen M, Baumann M, Freitag TL, Meri S, Saavalainen P, Jauhiainen M, Soliymani R, Kirjavainen T, Olsen P, Saarenpää-Heikkilä O, Rouvinen J, Roivainen M, Nohynek H, Jokinen J, Julkunen I, Kilpi T.

PLoS One. 2014 Dec 15;9(12):e114361. doi: 10.1371/journal.pone.0114361. eCollection 2014.

31.

Predictors to parental knowledge about childhood immunisation/EPI vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13).

Libwea JN, Kobela M, Ollgren J, Emah I, Tchio R, Nohynek H.

Pan Afr Med J. 2014 Mar 11;17:187. doi: 10.11604/pamj.2014.17.187.1911. eCollection 2014.

32.

Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.

Keller-Stanislawski B, Englund JA, Kang G, Mangtani P, Neuzil K, Nohynek H, Pless R, Lambach P, Zuber P.

Vaccine. 2014 Dec 12;32(52):7057-64. doi: 10.1016/j.vaccine.2014.09.052. Epub 2014 Oct 5. Review.

PMID:
25285883
33.

Using mathematical transmission modelling to investigate drivers of respiratory syncytial virus seasonality in children in the Philippines.

Paynter S, Yakob L, Simões EA, Lucero MG, Tallo V, Nohynek H, Ware RS, Weinstein P, Williams G, Sly PD.

PLoS One. 2014 Feb 27;9(2):e90094. doi: 10.1371/journal.pone.0090094. eCollection 2014.

34.

Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.

Root ED, Lucero M, Nohynek H, Anthamatten P, Thomas DS, Tallo V, Tanskanen A, Quiambao BP, Puumalainen T, Lupisan SP, Ruutu P, Ladesma E, Williams GM, Riley I, Simões EA.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3520-5. doi: 10.1073/pnas.1313748111. Epub 2014 Feb 18.

35.

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.

Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, Henao-Restrepo AM, Leach AJ, Klugman KP, Porter BD, Sá-Leão R, Scott JA, Nohynek H, O'Brien KL; WHO Pneumococcal Carriage Working Group.

Vaccine. 2013 Dec 17;32(1):165-79. doi: 10.1016/j.vaccine.2013.08.062. Review.

36.

Malnutrition: a risk factor for severe respiratory syncytial virus infection and hospitalization.

Paynter S, Ware RS, Lucero MG, Tallo V, Nohynek H, Weinstein P, Williams G, Sly PD, Simões EA.

Pediatr Infect Dis J. 2014 Mar;33(3):267-71. doi: 10.1097/INF.0000000000000096.

PMID:
24168980
37.

Colonisation endpoints in Streptococcus pneumoniae vaccine trials.

Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H; Pneumococcal Carriage Group (PneumoCarr).

Vaccine. 2013 Dec 17;32(1):153-8. doi: 10.1016/j.vaccine.2013.08.061. Epub 2013 Sep 7. Review.

PMID:
24016803
38.

EuSANH workshop "Reasons behind the differences in national vaccination schedules for under-five", European Public Health pre-conference workshop, Malta, 8 November 2012.

Theeten H, Nohynek H, Coenen TM; European Science Advisory Network for Health (EuSANH).

Vaccine. 2013 Oct 1;31(42):4694-6. doi: 10.1016/j.vaccine.2013.08.014. Epub 2013 Aug 17.

PMID:
23962536
39.

National Advisory Groups and their role in immunization policy-making processes in European countries.

Nohynek H, Wichmann O, D Ancona F; VENICE National Gatekeepers.

Clin Microbiol Infect. 2013 Dec;19(12):1096-105. doi: 10.1111/1469-0691.12315. Epub 2013 Aug 19. Review.

40.

No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.

Melén K, Partinen M, Tynell J, Sillanpää M, Himanen SL, Saarenpää-Heikkilä O, Hublin C, Olsen P, Ilonen J, Nohynek H, Syrjänen R, Kilpi T, Vuorela A, Kirjavainen T, Vaarala O, Julkunen I.

PLoS One. 2013 Aug 8;8(8):e68402. doi: 10.1371/journal.pone.0068402. eCollection 2013.

41.

Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.

Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H.

Vaccine. 2013 Dec 17;32(1):159-64. doi: 10.1016/j.vaccine.2013.06.105. Epub 2013 Jul 18. Review.

42.

Poor growth and pneumonia seasonality in infants in the Philippines: cohort and time series studies.

Paynter S, Ware RS, Lucero MG, Tallo V, Nohynek H, Simões EA, Weinstein P, Sly PD, Williams G; ARIVAC Consortium.

PLoS One. 2013 Jun 28;8(6):e67528. doi: 10.1371/journal.pone.0067528. Print 2013.

43.

Pathogen chip for respiratory tract infections.

Simões EA, Patel C, Sung WK, Lee CW, Loh KH, Lucero M, Nohynek H, Nai G, Thien PL, Koh CW, Chan YS, Ma J, Maurer-Stroh S, Carosone-Link P, Hibberd ML, Wong CW; ARIVAC Consortium.

J Clin Microbiol. 2013 Mar;51(3):945-53. doi: 10.1128/JCM.02317-12. Epub 2013 Jan 9.

44.

Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation.

Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J.

Vaccine. 2013 Jan 30;31(6):994-1007. doi: 10.1016/j.vaccine.2012.12.014. Epub 2012 Dec 16. Review. No abstract available.

PMID:
23246545
45.

The burden of childhood pneumonia in the developed world: a review of the literature.

Madhi SA, De Wals P, Grijalva CG, Grimwood K, Grossman R, Ishiwada N, Lee PI, Nascimento-Carvalho C, Nohynek H, O'Brien KL, Vergison A, Wolter J.

Pediatr Infect Dis J. 2013 Mar;32(3):e119-27. doi: 10.1097/INF.0b013e3182784b26. Review.

PMID:
23099423
46.

Sunshine, rainfall, humidity and child pneumonia in the tropics: time-series analyses.

Paynter S, Weinstein P, Ware RS, Lucero MG, Tallo V, Nohynek H, Barnett AG, Skelly C, Simões EA, Sly PD, Williams G; ARIVAC Consortium.

Epidemiol Infect. 2013 Jun;141(6):1328-36. doi: 10.1017/S0950268812001379. Epub 2012 Aug 13.

PMID:
22884022
47.

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines.

Sanvictores DH, Lucero MG, Nohynek H, Tallo VL, Tanskanen A, Nillos LT, Williams G; ARIVAC Consortium.

BMC Res Notes. 2012 Jun 7;5:274. doi: 10.1186/1756-0500-5-274.

48.

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.

Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen SL, Hublin C, Julkunen I, Olsén P, Saarenpää-Heikkilä O, Kilpi T.

PLoS One. 2012;7(3):e33536. doi: 10.1371/journal.pone.0033536. Epub 2012 Mar 28.

49.

Geographic Information System and tools of spatial analysis in a pneumococcal vaccine trial.

Tanskanen A, Nillos LT, Lehtinen A, Nohynek H, Sanvictores DH, Simões EA, Tallo VL, Lucero MG; ARIVAC Consortium.

BMC Res Notes. 2012 Jan 20;5:51. doi: 10.1186/1756-0500-5-51.

50.

Vaccination competence of public health nurses.

Nikula A, Nohynek H, Puukka P, Leino-Kilpi H.

Public Health Nurs. 2011 Nov-Dec;28(6):533-42. doi: 10.1111/j.1525-1446.2011.00943.x. Epub 2011 May 2.

PMID:
22092463

Supplemental Content

Loading ...
Support Center